Search
for
Sort by
Research 121–150 of 1000+
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Synopsis: 2005 Annual Meeting of the American Society of Andrology
- Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices
- Hormonal manipulation of benign prostatic hyperplasia
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Update on the Potential of <i>Punica granatum</i> L. Traditional Uses and Pharmacological Uses: A Review
- Bicalutamide: A review
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Skin manifestations of hyperandrogenism: an update
- Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo): a case report
- Hot Flashes in a Young Girl: A Wake-up Call Concerning Serenoa repens Use in Children
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- Review of Hair Follicle Dermal Papilla cells as <i>in vitro</i> screening model for hair growth
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Hyperadrenocorticism in Ferrets
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Nonclassic Congenital Adrenal Hyperplasia
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates